Traws Pharma Files 8-K on Operations
Ticker: TRAW · Form: 8-K · Filed: May 16, 2024 · CIK: 1130598
| Field | Detail |
|---|---|
| Company | Traws Pharma, Inc. (TRAW) |
| Form Type | 8-K |
| Filed Date | May 16, 2024 |
| Risk Level | low |
| Pages | 2 |
| Reading Time | 2 min |
| Sentiment | neutral |
Sentiment: neutral
Topics: operations, financial-condition, sec-filing
TL;DR
Traws Pharma (fka Onconova) filed an 8-K on May 16th. Check for operational/financial updates.
AI Summary
Traws Pharma, Inc. (formerly Onconova Therapeutics, Inc.) filed an 8-K on May 16, 2024, reporting on its results of operations and financial condition. The company, incorporated in Delaware, is located at 12 Penns Trail, Newtown, PA. The filing does not contain specific financial figures or operational details beyond its classification as a pharmaceutical preparations company.
Why It Matters
This 8-K filing indicates Traws Pharma is providing an update on its financial condition and operational results to the SEC. Investors should review the full filing for specific details.
Risk Assessment
Risk Level: low — This is a standard 8-K filing reporting on operations and financial condition, without immediate news of significant events like mergers, bankruptcies, or major regulatory actions.
Key Players & Entities
- Traws Pharma, Inc. (company) — Registrant
- Onconova Therapeutics, Inc. (company) — Former company name
- May 16, 2024 (date) — Date of report
- 12 Penns Trail Newtown, PA 18940 (address) — Business address
- 267-759-3680 (phone_number) — Business phone
FAQ
What is the primary purpose of this 8-K filing for Traws Pharma, Inc.?
The filing is a Current Report (8-K) pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934, reporting on the 'Results of Operations and Financial Condition' of Traws Pharma, Inc.
When was the earliest event reported in this filing?
The date of the earliest event reported is May 16, 2024.
What was Traws Pharma, Inc. formerly known as?
Traws Pharma, Inc. was formerly known as Onconova Therapeutics, Inc.
In which state is Traws Pharma, Inc. incorporated?
Traws Pharma, Inc. is incorporated in Delaware.
What is the business address and phone number listed for Traws Pharma, Inc.?
The business address is 12 Penns Trail, Newtown, PA 18940, and the business phone number is (267) 759-3680.
Filing Stats: 451 words · 2 min read · ~2 pages · Grade level 11 · Accepted 2024-05-16 16:19:18
Filing Documents
- tm2414653d1_8k.htm (8-K) — 22KB
- tm2414653d1_ex99-1.htm (EX-99.1) — 59KB
- 0001104659-24-062544.txt ( ) — 256KB
- tmb-20240516.xsd (EX-101.SCH) — 3KB
- tmb-20240516_lab.xml (EX-101.LAB) — 33KB
- tmb-20240516_pre.xml (EX-101.PRE) — 22KB
- tm2414653d1_8k_htm.xml (XML) — 3KB
02 Results of Operations and Financial Condition
Item 2.02 Results of Operations and Financial Condition. On May 16, 2024, Traws Pharma, Inc. (the "Company") issued a press release announcing its financial results for the quarter ended March 31, 2024, a copy of which is attached hereto as Exhibit 99.1 and incorporated herein by reference. The information contained in this Form 8-K (including the exhibit hereto) shall not be deemed "filed" for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the "Exchange Act"), or incorporated by reference in any filing under the Securities Act of 1933, as amended, or the Exchange Act, except as shall be expressly set forth by specific reference in such a filing. Exhibit No. Exhibit 99.1 Press release issued by the Company dated May 16, 2024 104 The cover page from this Current Report on Form 8-K, formatted in Inline XBRL.
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. TRAWS PHARMA, INC. Date: May, 16, 2024 By: /s/ MARK GUERIN Mark Guerin Chief Financial Officer